Masimo Corporation Awarded Contract by Premier For


                   Masimo Signal Extraction Pulse Oximetry
         Agreement Provides More Than 1500 Hospitals and Other Healthcare
                   Sites Access to Masimo SET(R) Technology


  IRVINE, Calif., Sept. 3 /PRNewswire/ -- Masimo, the innovator of motion
and low perfusion tolerant pulse oximetry, today announced that Premier, one
of the nation's leading group purchasing organizations (GPOs), has awarded a
contract to Masimo under which Masimo will make available the Masimo Signal
Extraction pulse oximetry technology (Masimo SET(R)) to Premier's more than
1,500 affiliated hospital facilities.  The three-year agreement is effective
as of September 1, 2002. 
Kevin Mosher, President of Masimo Americas stated, "Masimo offers
Premier's member hospitals the most comprehensive clinical validation of
safety and efficacy for any motion and low perfusion tolerant pulse oximetry
technology as well as the broadest and deepest OEM offering of motion and low
perfusion tolerant pulse oximetry on the market.  In addition, this agreement
offers Premier member hospitals the most extensive array of motion and low
perfusion tolerant products and programs, such as guaranteed reductions in
adhesive sensor utilization or capitated reusable sensor programs, depending
upon the unique needs of each facility." 
"Masimo's mission has been to improve patient care and reduce the cost of
care by making patient monitoring reliable and taking it to new sites and
applications," said Kevin Mosher, President of Masimo, Americas.  "With our
invention of Signal Extraction Technology, we solved the problem that plagued
pulse oximetry, false alarms and missed events due to patient motion and low
blood flow.  Physicians around the world have sought out Masimo SET pulse
oximetry due to its revolutionary performance.  We are delighted to be able to
now offer Premier member hospitals Masimo SET technology; this is a big step
towards accomplishing our mission." 
"The healthcare marketplace is evolving so quickly and on so many levels
such as features, innovations and pricing. Continuously improving our contract
portfolio reflects our members' expectations that Premier continues to lead
with new contracts and enhanced contracting strategies," said Howard Sanders,
executive responsible for Premier's group purchasing services. "Multi-sourcing
for products with high physician preference is consistent with Premier's
contracting framework to help hospitals reduce overall costs while maintaining
high standards in healthcare delivery." 
Mr. Mosher added, "Today's hospitals are forced to deal with staffing
shortages and pressures to reduce costs and medical errors. Masimo SET pulse
oximetry offers clinicians a monitor that has been proven to work exceedingly
well in a variety of medically challenging circumstances.  This level of
reliability has been shown to reduce the cost of care, and has been linked to
reduced medical errors and improved patient care.  We are anxious to offer our
technology and a variety of flexible programs, whether the facility uses
adhesive or reusable sensors, to Premier hospitals to help them meet their
objective of improving their process of care." 
  Masimo Corporation, founded in 1989, is the innovator and leader of motion
and low perfusion tolerant pulse oximetry.  Masimo develops, licenses and
markets advanced medical signal processing technologies and products for the
non-invasive monitoring of vital signs.  Masimo Signal Extraction Technology
represents a fundamental departure from conventional pulse oximetry
technologies.  Over 50 independent and objective, published studies have
demonstrated that Masimo Signal Extraction Technology substantially overcomes
the limitations of conventional pulse oximeters in accurately measuring
arterial blood oxygen saturation levels and pulse rates in the presence of
patient movement and low perfusion.  To date, Masimo has licensed its Signal
Extraction pulse oximetry technology to over 35 international patient
monitoring system providers, which make up over 60% of the world's pulse
oximeter shipments.  Masimo is headquartered in Irvine, California.
Additional information about Masimo and its products can be found on the
company's web site www.masimo.com . 
  Premier, Inc., is a strategic alliance in U.S. healthcare, entirely owned
by more than 200 of the nation's leading hospital and healthcare systems.
These systems operate or are affiliated with approximately 1,530 hospital
facilities in 50 states and hundreds of other care sites.  Premier provides an
array of resources supporting health services delivery.  Among these resources
are supply chain management support and group purchasing for more than $14
billion annually in supplies and equipment.  Premier also offers insurance
programs, performance improvement services of many kinds including substantial
comparative databases and associated benchmarking applications, clinical
technology services, and practice support services. Premier is headquartered
in San Diego, Calif., with offices in Chicago, Ill.; Charlotte, N.C.; and
Washington, D.C. 
                  MAKE YOUR OPINION COUNT -  Click Here 
           http://tbutton.prnewswire.com/prn/11690X28801456
  

SOURCE  Masimo Corporation 


    -0-                             09/03/2002
    /CONTACT:  Brad Langdale of Masimo Corporation, +1-949-253-6404/


/Web site:  http://www.masimo.com / 
CO:  Masimo Corporation; Premier, Inc.
ST:  California
IN:  HEA MTC BIO CPR
SU:  CON 
-0- Sep/03/2002 21:43 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.